In this enlightening episode, Dr. Robert Gish, a renowned expert in hepatology, explores the complexities of Hepatitis Delta (HDV), a deadly form of viral hepatitis. Dr. Gish emphasizes why all Hepatitis B (HBV) patients must be tested for HDV total antibodies, and if positive, further tested for HDV RNA quantification. He explains the significant risks HDV poses to liver health, its interaction with HBV, and the urgent need for proper diagnosis and management.

With new treatments on the horizon, Dr. Gish highlights the latest advancements in therapy, offering hope for more effective care. Whether you're a healthcare professional or someone interested in learning more about Hepatitis Delta, this episode provides crucial insights into testing, treatment options, and the future of HDV care.

Tune in for valuable info on how to navigate the challenges of Hepatitis Delta and the promising new approaches to treatment.

Be sure to send any questions to Dr. Gish via email rgish@robertgish.com or via his website www.robertgish.com.  Thank you for listening!